[Retracted] Efficacy Analysis of Comprehensive Nursing in the Care of Ovarian Carcinoma Treated with Paclitaxel Combined with Nedaplatin

Table 3

Incidence of adverse reactions in the two groups.

Classification	Observation group ()	Control group ()
Myelosuppression	0 (0.00)	2 (2.50)	—	—
Hair loss	2 (2.00)	4 (5.00)	—	—
Gastrointestinal discomfort	2 (2.00)	4 (5.00)
Anemia	0 (0.00)	2 (2.50)	—	—
Total incidence (%)	4 (4.00)	12 (15.00)	6.64	0.01